Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Cook

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Journal of Clinical Pharmacology|July 2, 2016
Utility of Model-Based Approaches for Informing Dosing Recommendations in Specific Populations: Report From the Public AAPS WorkshopIslam R Younis, J Robert Powell, Amin Rostami-Hodjegan, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 2, 2009
Comparison of different algorithms for predicting clinical drug-drug interactions, based on the use of CYP3A4 in vitro data: predictions of compounds as precipitants of interactionOdette A Fahmi, Susan Hurst, David Plowchalk, et al.
Molecular Pharmaceutics|December 18, 2019
ICH M9 Guideline in Development on Biopharmaceutics Classification System-Based Biowaivers: An Industrial Perspective from the IQ ConsortiumPhilip Bransford, Jack Cook, Manish Gupta, et al.
British Journal of Clinical Pharmacology|February 19, 2008
Application of CYP3A4 in vitro data to predict clinical drug-drug interactions; predictions of compounds as objects of interactionKuresh A Youdim, Aref Zayed, Maurice Dickins, et al.
Annual Review of Pharmacology and Toxicology|October 9, 2020
Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug TherapyAdam S Darwich, Thomas M Polasek, Jeffrey K Aronson, et al.
Clinical Pharmacology and Therapeutics|May 25, 2022
Clinical Relevance of Hepatic and Renal P-gp/BCRP Inhibition of Drugs: An International Transporter Consortium PerspectiveKunal S Taskar, Xinning Yang, Sibylle Neuhoff, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 20, 2021
Harnessing formulation and clinical pharmacology knowledge for efficient pediatric drug development: Overview and discussions from M-CERSI pediatric formulation workshop 2019Yuet Mei Khong, Jing Liu, Jack Cook, et al.
Clinical Pharmacology and Therapeutics|March 23, 2024
Considerations for Industry-Preparing for the FDA Model-Informed Drug Development (MIDD) Paired Meeting ProgramGerald R Galluppi, Malidi Ahamadi, Souvik Bhattacharya, et al.
Clinical Pharmacology and Therapeutics|May 15, 2021
Industrial Perspective on the Benefits Realized From the FDA's Model-Informed Drug Development Paired Meeting Pilot ProgramGerald R Galluppi, Satjit Brar, Luzelena Caro, et al.
Clinical Pharmacology and Therapeutics|October 16, 2021
Roadmap to 2030 for Drug Evaluation in Older AdultsQi Liu, Janice B Schwartz, Patricia W Slattum, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Clinical Pharmacology|July 2, 2016
Utility of Model-Based Approaches for Informing Dosing Recommendations in Specific Populations: Report From the Public AAPS WorkshopIslam R Younis, J Robert Powell, Amin Rostami-Hodjegan, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 2, 2009
Comparison of different algorithms for predicting clinical drug-drug interactions, based on the use of CYP3A4 in vitro data: predictions of compounds as precipitants of interactionOdette A Fahmi, Susan Hurst, David Plowchalk, et al.
Molecular Pharmaceutics|December 18, 2019
ICH M9 Guideline in Development on Biopharmaceutics Classification System-Based Biowaivers: An Industrial Perspective from the IQ ConsortiumPhilip Bransford, Jack Cook, Manish Gupta, et al.
British Journal of Clinical Pharmacology|February 19, 2008
Application of CYP3A4 in vitro data to predict clinical drug-drug interactions; predictions of compounds as objects of interactionKuresh A Youdim, Aref Zayed, Maurice Dickins, et al.
Annual Review of Pharmacology and Toxicology|October 9, 2020
Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug TherapyAdam S Darwich, Thomas M Polasek, Jeffrey K Aronson, et al.
Clinical Pharmacology and Therapeutics|May 25, 2022
Clinical Relevance of Hepatic and Renal P-gp/BCRP Inhibition of Drugs: An International Transporter Consortium PerspectiveKunal S Taskar, Xinning Yang, Sibylle Neuhoff, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 20, 2021
Harnessing formulation and clinical pharmacology knowledge for efficient pediatric drug development: Overview and discussions from M-CERSI pediatric formulation workshop 2019Yuet Mei Khong, Jing Liu, Jack Cook, et al.
Clinical Pharmacology and Therapeutics|March 23, 2024
Considerations for Industry-Preparing for the FDA Model-Informed Drug Development (MIDD) Paired Meeting ProgramGerald R Galluppi, Malidi Ahamadi, Souvik Bhattacharya, et al.
Clinical Pharmacology and Therapeutics|May 15, 2021
Industrial Perspective on the Benefits Realized From the FDA's Model-Informed Drug Development Paired Meeting Pilot ProgramGerald R Galluppi, Satjit Brar, Luzelena Caro, et al.
Clinical Pharmacology and Therapeutics|October 16, 2021
Roadmap to 2030 for Drug Evaluation in Older AdultsQi Liu, Janice B Schwartz, Patricia W Slattum, et al.
Pageof 3